Combining cannabidiol and delta-9-tetrahydrocannabinol at a 50:3 ratio - a new therapeutic strategy for APPSwe/PS1ΔE9 transgenic mice?
{{output}}
Preclinical evidence suggests that cannabidiol (CBD) can ameliorate Alzheimer's disease (AD)-related pathologies, including amyloid-β aggregation and tau hyperphosphorylation, and can reverse and prevent cognitive decline in AD rodent models. Interestingly, ... ...
